Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2018-12-18 2018-11-29
Drug Identification Number 00363839 00363839
Brand name BUSCOPAN BUSCOPAN
Common or Proper name Busopan 20MG/1ML Busopan 20MG/1ML
Company Name SANOFI CONSUMER HEALTH INC SANOFI CONSUMER HEALTH INC
Ingredients HYOSCINE BUTYLBROMIDE HYOSCINE BUTYLBROMIDE
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 X 1ml 10 X 1ml
ATC code A03BB A03BB
ATC description BELLADONNAAND DERIVATIVES, PLAIN BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-12-24 2018-12-24
Actual start date
Estimated end date 2019-01-08 2019-01-08
Actual end date 2018-12-14
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments Back order avoided
Health Canada comments